Total Payments
$517.27
2024 Payments
$105.95
Companies
6
Transactions
11
Medicare Patients
730
Medicare Billing
$87,086
Payment Breakdown by Category
Food & Beverage$317.27 (61.3%)
Consulting$200.00 (38.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $317.27 | 10 | 61.3% |
| Consulting Fee | $200.00 | 1 | 38.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $216.07 | 5 | $0 (2024) |
| CapsoPro Services LLC | $200.00 | 1 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $45.41 | 2 | $0 (2023) |
| Braintree Laboratories, Inc. | $20.61 | 1 | $0 (2024) |
| Janssen Biotech, Inc. | $19.00 | 1 | $0 (2024) |
| PFIZER INC. | $16.18 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $105.95 | 5 | ABBVIE INC. ($50.16) |
| 2023 | $77.26 | 3 | ABBVIE INC. ($54.16) |
| 2022 | $134.06 | 2 | ABBVIE INC. ($111.75) |
| 2020 | $200.00 | 1 | CapsoPro Services LLC ($200.00) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: IMMUNOLOGY | ||||||
| 06/05/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 04/02/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug), SUTAB | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: GI COLON PREP | ||||||
| 01/31/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Immunology | ||||||
| 01/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/20/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/12/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $111.75 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/17/2020 | CapsoPro Services LLC | — | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 434 | 493 | $362,814 | $53,058 |
| 2022 | 6 | 184 | 203 | $121,240 | $24,642 |
| 2021 | 4 | 68 | 89 | $21,269 | $6,353 |
| 2020 | 3 | 44 | 44 | $10,668 | $3,032 |
Total Patients
730
Total Services
829
Medicare Billing
$87,086
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 86 | 86 | $112,832 | $9,809 | 8.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 79 | 79 | $27,808 | $8,778 | 31.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 44 | 92 | $22,816 | $8,596 | 37.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 35 | 35 | $59,115 | $7,431 | 12.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 34 | 37 | $16,169 | $5,320 | 32.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 65 | 65 | $64,480 | $4,162 | 6.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 18 | 18 | $20,898 | $3,521 | 16.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 29 | $7,511 | $2,907 | 38.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 11 | 11 | $12,980 | $2,157 | 16.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 22 | 28 | $616.00 | $227.83 | 37.0% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $17,589 | $149.43 | 0.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 53 | 53 | $18,656 | $7,817 | 41.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 28 | 30 | $13,110 | $4,973 | 37.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 34 | 34 | $44,608 | $4,551 | 10.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 34 | $8,422 | $2,759 | 32.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 32 | 32 | $31,744 | $2,423 | 7.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 20 | $4,700 | $2,120 | 45.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 27 | 48 | $8,640 | $2,724 | 31.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $4,908 | $1,625 | 33.1% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 15 | 15 | $3,750 | $1,196 | 31.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 11 | 11 | $3,971 | $808.12 | 20.4% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 13 | 13 | $5,564 | $1,603 | 28.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 14 | 14 | $4,900 | $1,355 | 27.7% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2020 | 17 | 17 | $204.00 | $74.07 | 36.3% |
About Dr. Richard Hsu, M.D
Dr. Richard Hsu, M.D is a Gastroenterology healthcare provider based in Aurora, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679521827.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Hsu, M.D has received a total of $517.27 in payments from pharmaceutical and medical device companies, with $105.95 received in 2024. These payments were reported across 11 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($317.27).
As a Medicare-enrolled provider, Hsu has provided services to 730 Medicare beneficiaries, totaling 829 services with total Medicare billing of $87,086. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology, Gastroenterology
- Location Aurora, IL
- Active Since 05/04/2006
- Last Updated 12/22/2022
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1679521827
Products in Payments
- RINVOQ (Biological) $163.64
- ENTYVIO (Biological) $45.41
- VIBERZI (Drug) $27.35
- SKYRIZI (Biological) $25.08
- SUFLAVE (Drug) $20.61
- STELARA (Biological) $19.00
- XELJANZ (Drug) $16.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Aurora
Dr. Steven Edmundowicz, Md, MD
Gastroenterology — Payments: $229,083
Gastroenterology $229,083
Mihir Wagh, Md, MD
Gastroenterology — Payments: $199,297
Gastroenterology $199,297
Raj Shah, Md, MD
Gastroenterology — Payments: $146,129
Gastroenterology $146,129
Dr. Rachna Arora, M.d, M.D
Gastroenterology — Payments: $90,741
Gastroenterology $90,741
Dr. Amar Bansal, M.d, M.D
Gastroenterology — Payments: $65,472
Gastroenterology $65,472
Jennifer Christie, Md, MD
Gastroenterology — Payments: $55,237
Gastroenterology $55,237